Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2013
11/20/2013EP1709044B2 Oxazolidinone-quinolone hybrid antibiotics
11/20/2013CN103403010A Inhibitors of polo-like kinase
11/20/2013CN103403004A Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
11/20/2013CN103403003A Bridged piperidine derivatives
11/20/2013CN103402996A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD)
11/20/2013CN103402520A Substituted imidazoquinoline derivatives
11/20/2013CN103402519A Therapeutic agent for tumor
11/20/2013CN103396416A Preparation method of moxifloxacin impurity F
11/20/2013CN103396415A Novel substituted imidazoquinolines
11/20/2013CN102617554B Two-photon fluorescent probe taking naphthaline as matrix as well as preparation method and application thereof
11/20/2013CN102131807B Pyrazolopyridine kinase inhibitors
11/20/2013CN102015680B New substituted indolin-2-one derivatives and use thereof as p38 mitogen-activated kinase inhibitors
11/20/2013CN101939320B Polymorphic form
11/20/2013CN101896178B Heterocyclic compounds as CRTH2 receptor antagonists
11/20/2013CN101790532B Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
11/20/2013CN101641352B Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
11/19/2013US8586745 Switchable special effect substances
11/19/2013US8586737 Process of a quaternary ammonium salt using phosphate
11/19/2013US8586609 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/19/2013US8586605 Fused amino pyridine as HSP90 inhibitors
11/19/2013US8586604 Inhibitors of the microsomal prostaglandin E2 synthase-1
11/19/2013US8586603 Aminotetraline derivatives
11/19/2013US8586585 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/19/2013US8586581 Ethynyl compounds useful for treatment of CNS disorders
11/19/2013US8586571 Heterocyclic compound
11/19/2013US8586570 Sox-based kinase sensor
11/19/2013US8586291 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571
11/19/2013CA2692922C Azaindole-indole coupled derivatives, preparation methods and uses thereof
11/19/2013CA2671857C 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives
11/19/2013CA2633624C 3,5-substituted piperidine compounds as renin inhibitors
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/14/2013WO2013170165A1 Antibacterial agents
11/14/2013WO2013170112A1 Nampt inhibitors
11/14/2013WO2013169964A1 Heteroaryl compounds and methods of use thereof
11/14/2013WO2013169546A1 Pyrazole compounds as sglt1 inhibitors
11/14/2013WO2013168012A1 Compositions and methods for the treatment of respiratory disorders
11/14/2013WO2013167730A1 Alpha-carbolines for the treatment of cancer
11/14/2013WO2013167633A1 Acrylamide compounds for combating invertebrate pests
11/14/2013WO2013167495A1 Bicyclically substituted uracils and the use thereof
11/14/2013WO2013167403A1 Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
11/14/2013WO2012154679A8 Tricyclic pyrazole sulfonamide compounds and methods of making and using same
11/14/2013US20130303770 Radiolabelled phenylimidazole-based ligands
11/14/2013US20130303764 Processes and intermediates for producing azaindoles
11/14/2013US20130303756 Methods and compositions for preparing noribogaine from voacangine
11/14/2013US20130303559 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
11/14/2013US20130303553 Fused heterocyclic compounds
11/14/2013US20130303535 Novel bicyclic heterocyclic compound
11/14/2013US20130303534 Compounds and methods for kinase modulation, and indications therefor
11/14/2013US20130303532 Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders
11/14/2013US20130303529 Fused heterocyclic derivatives and methods of use
11/14/2013US20130303517 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
11/14/2013US20130303516 Novel triazine compounds
11/14/2013US20130303515 Novel compounds useful for the treatment of metabolic and inflammatory diseases
11/14/2013US20130303511 Nampt inhibitors
11/14/2013US20130303508 Nampt inhibitors
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303504 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors
11/14/2013US20130303375 Plant growth regulating compounds
11/14/2013US20130302282 Inhibitors of Hepatitis C Virus
11/13/2013EP2662374A1 Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor
11/13/2013EP2662373A1 Salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
11/13/2013EP2662372A1 Alpha-carbolines for the treatment of cancer
11/13/2013EP2662357A1 Novel bicyclic compound or salt thereof
11/13/2013EP2661435A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
11/13/2013EP2661433A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
11/13/2013EP2661268A2 Inhibitors of polo-like kinase
11/13/2013EP2661265A1 Quinolines and aza-quinolines as crth2 receptor modulators
11/13/2013EP2234485B1 Stable laquinimod preparations
11/13/2013CN103391938A Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
11/13/2013CN103391924A Novel antiviral compounds
11/13/2013CN103387575A Preparation method for paliperidone, and key intermediates of the paliperidone
11/13/2013CN102911979B Method for preparing levo-praziquantel
11/13/2013CN102105451B Glucokinase activators
11/13/2013CN102105448B Phenoxypyridinylamide derivatives and use thereof in the treatment of PDE4 mediated disease states
11/13/2013CN102083828B Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors
11/13/2013CN102020646B Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
11/13/2013CN102015705B Fused heterocyclic derivative and use thereof
11/13/2013CN101671336B Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
11/13/2013CN101605787B Compounds modulating c-fms and/or c-kit activity and uses therefor
11/13/2013CN101506207B Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
11/12/2013US8580815 Derivatives of azaindoles as inhibitors of protein kinases ABL and SRC
11/12/2013US8580809 Filamin A-binding anti-inflammatory analgesic
11/12/2013US8580808 Filamin A-binding anti-inflammatory analgesic
11/12/2013US8580788 Opioid antagonists
11/12/2013US8580398 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
11/12/2013US8580391 Material for organic electroluminescence devices and organic electroluminescence device using the material
11/12/2013CA2752981C Indole derivatives as crth2 receptor antagonists
11/12/2013CA2675419C Heterocyclic-substituted piperidine compounds and the uses thereof
11/12/2013CA2565184C Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/07/2013WO2013166396A2 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
11/07/2013WO2013166110A1 Tlr-agonist-conjugated antibody recruiting molecules (tlr_arms)
11/07/2013WO2013164839A2 Amorphous form of apixaban, process of preparation and compositions thereof
11/07/2013WO2013164790A1 L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists
11/07/2013WO2013164323A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators for use in the treatment of parkinson's disease
11/07/2013US20130296555 Beta-lactamase inhibitors
11/07/2013US20130296362 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/07/2013US20130296361 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
11/07/2013US20130296358 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
11/07/2013US20130296352 Pyrazoloquinoline derivatives
11/07/2013US20130296341 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 646